The association between apolipoprotein E and multiple sclerosis
- 6 June 2006
- journal article
- review article
- Published by Wiley in European Journal of Neurology
- Vol. 13 (6), 573-580
- https://doi.org/10.1111/j.1468-1331.2006.01360.x
Abstract
The article is a complete literature study that investigates the association between apolipoprotein E (Apo E) and multiple sclerosis (MS). Apo E is an important factor in transport, uptake, and redistribution of cholesterol, which is significant to remodelling and repair of nerve tissue. Apo E is involved in neurodegenerative diseases and the most well known association is between Apo ɛ4 and Alzheimer's disease. Only one study found that homozygosity for Apo ɛ4 does cause an increased risk of developing MS. No results indicate that heterozygosity for Apo ɛ4 causes a greater risk of developing MS. No association between the Apo ɛ4 allele and MS subgroups, age of onset, and gender has been found. The association between Apo ɛ4 and relapse rate is contradictory. Most results confirm the hypothesis about an association between the Apo ɛ4 allele and increased disease progression. Two longitudinal studies found an association between Apo ɛ4 and increased disease progression. Half of the cross‐sectional studies found the same association. Four of seven published studies examining the association between Apo ɛ4 and increased disease progression using magnetic resonance imaging (MRI) found a significant association. Apo ɛ4 appears to be a predisposing factor to a faster disease progression in MS.Keywords
This publication has 38 references indexed in Scilit:
- APOE and risk of cognitive impairment in multiple sclerosisActa Neurologica Scandinavica, 2009
- Accelerated evolution of brain atrophy and “black holes” in MS patients with APOE‐ε4Annals of Neurology, 2004
- Multiple susceptibility loci for multiple sclerosisHuman Molecular Genetics, 2002
- Association of Polymorphisms in the Apolipoprotein E Region with Susceptibility to and Progression of Multiple SclerosisAmerican Journal of Human Genetics, 2002
- No association between the APOE epsilon 4 allele and outcome and susceptibility in primary progressive multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Polymorphisms of apolipoprotein E; outcome and susceptibility in multiple sclerosisMultiple Sclerosis Journal, 2000
- Association of the APOE epsilon 4 allele with disease activity in multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 1999
- Apolipoprotein E and the CNS Response to InjuryJournal of Cerebral Blood Flow & Metabolism, 1998
- Apo E genotypes in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's diseaseMolecular and Cellular Probes, 1994
- Rating neurologic impairment in multiple sclerosisNeurology, 1983